COMPANY NAME
Chelsea Therapeutics International Ltd. (CHTP)

QUOTE
dollar sign1.88
-0.01 (-0.53%)
1.92
1.86
2.04
0.76
VOLUME
Today
0
Avg
VALUATION
n/a
EPS
$n/a
Mkt Cap
94
STOCKHOLDERS
Dividend
n/a
Yield
n/a
Outstanding
Shares
50
Inst Owner
PERFORMANCE CHART

GAINS/LOSSES
200920082007200620052004
Stock Price 101.5%-81.8%92.4%35.9%n/an/a
FINANCIALS IN MILLIONS USD
200920082007200620052004
Revenue 0 0 0 0 0 0
Net Income - $26- $35- $15- $9- $8- $3
Cash Flow - $30- $22- $11- $7- $7- $2
FUNDAMENTALS
200920082007200620052004
Net Margin -75.0%-79.5%-23.9%-53.6%-230.9%-27.1%
ROI -200.5%-142.9%-26.0%-61.3%-332.8%-28.7%
ROA 0.0%0.0%0.0%0.0%0.0%0.0%
QUARTERLY EARNINGS CHART
You need to upgrade your Flash Player


EARNINGS CALLS

2013
30 April 2013
01 May 2013
2012
29 February 2012
06 March 2012
31 July 2012
07 August 2012
07 November 2012
2011
02 March 2011
26 July 2011
31 October 2011
02 November 2011
2010
10 March 2010
29 April 2010
27 July 2010
01 November 2010
2009
04 March 2009
06 May 2009
05 August 2009
02 November 2009
TRANSCRIPTS

DOCUMENTS



COMPANY DESCRIPTION
MORE...
COMPANY NEWS
MORE...
WEB NEWS
MORE...
SEC FILINGS
MORE...
BLOGGERS
MORE...
ANNUAL EARNINGS CHART
You need to upgrade your Flash Player


MANAGEMENT

13950 Ballantyne Corporate Place, Suite 325 Charlotte, NC 28277 USA
+1-704-3411516

http://www.chelsearx.com

Kevan Clemens
Chairman of the Board

Simon Pedder
President, Chief Executive Officer, Director

Michael J. Roberts
Senior Director, Business Development

J.Nick Riehle
Chief Financial Officer, Vice President - Administration

L.Arthur Hewitt
Vice President - Drug Development

Keith W. Schmidt
Vice President - Sales and Marketing